Serum MMPs 7–9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease

References

• Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1756–67.
   PubMed Web of Science ®Google Scholar
• Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010;30:80–9.
   PubMed Web of Science ®Google Scholar
• Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621–30.
   PubMed Web of Science ®Google Scholar
• Ravi A, Garg P, Sitaraman SV. Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm Bowel Dis 2007;13:97–107.
   PubMed Web of Science ®Google Scholar
• Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, Taylor CJ, Evans GS. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814–22.
   PubMed Web of Science ®Google Scholar
• Matsuno K, Adachi Y, Yamamoto H, Goto A, Arimura Y, Endo T, Itoh F, Imai K. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 2003;38:348–54.
   PubMed Web of Science ®Google Scholar
• Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;115:3719–27.
   PubMed Web of Science ®Google Scholar
• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000;120:241–6.
   PubMed Web of Science ®Google Scholar
• Mäkitalo L, Sipponen T, Kärkkäinen P, Kolho KL, Saarialho-Kere U. Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values. Int J Colorectal Dis 2009;24:1157–67.
   PubMed Web of Science ®Google Scholar
• Sangfelt P, Carlson M, Thörn M, Lööf L, Raab Y. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol 2001;96:1085–90.
   PubMed Web of Science ®Google Scholar
• Örem A, Değer O, Cimşit G, Bahadir S. Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta 1997;264:49–56.
   PubMed Web of Science ®Google Scholar
• Adeyemi EO, Neumann S, Chadwick VS, Hodgson HJ, Pepys MB. Circulating human leucocyte elastase in patients with inflammatory bowel disease. Gut 1985;26:1306–11.
   PubMed Web of Science ®Google Scholar
• Hayden DM, Forsyth C, Keshavarziana A. The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states. J Surg Res 2011;168:315–24.
   Web of Science ®Google Scholar
• Sandborn WJ. Strategies for targeting tumour necrosis factor in IBD. Best Pract Res Clin Gastroenterol 2003;17:105–17.
   PubMed Web of Science ®Google Scholar
• Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007;132:863–73.
   PubMed Web of Science ®Google Scholar
• Rintamäki H, Salo HM, Vaarala O, Kolho KL. New means to monitor the effect of glucocorticoid therapy in children. World J Gastroenterol 2010;16:1104–9.
   PubMed Web of Science ®Google Scholar
• Kolho K-L, Raivio T, Lindahl H, Savilahti E. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol 2006;41:720–5.
   PubMed Web of Science ®Google Scholar
• Rautelin H, Tervahartiala T, Lauhio A, Sorsa T, Kolho KL. Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis. Scand J Clin Lab Invest 2010;70:492–6.
   PubMed Web of Science ®Google Scholar
• Tuomainen AM, Nyyssönen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007;27:2722–8.
   PubMed Web of Science ®Google Scholar
• Haapamäki J, Roine RP, Sintonen H, Kolho KL. Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity. J Paediatr Child Health 2011; Epub ahead of print.
   Google Scholar
• Kofla-Dlubacz A, Matusiewicz M, Iwanczak B. Correlation of MMP-3 and MMP-9 with Crohn's Disease activity in children. Dig Dis Sci 2011; Epub ahead of print.
   Google Scholar
• Mäkitalo L, Kolho KL, Karikoski R, Anthoni H, Saarialho-Kere U. Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease. Scand J Gastroenterol 2010;45:862–71.
   PubMed Web of Science ®Google Scholar
• Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. Am J Gastroenterol 2002;97:2350–6.
   PubMed Web of Science ®Google Scholar
• Marti HP, McNeil L, Thomas G, Davies M, Lovett DH. Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J 1992;285:899–905.
   PubMed Web of Science ®Google Scholar
• Moinzadeh P, Krieg T, Hellmich M, Brinckmann J, Neumann E, Müller-Ladner U, Elevated MMP-7 levels in patients with systemic sclerosis: Correlation with pulmonary involvement. Exp Dermatol 2011;20:770–3.
   PubMed Web of Science ®Google Scholar
• Musiał K, Zwolińska D. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis. Cell Stress Chaperones 2011;16:163–71.
   PubMed Web of Science ®Google Scholar
• Martínez-Fernandez A, García-Albeniz X, Pineda E, Visa L, Gallego R, Codony-Servat J, Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients. Ann Surg Oncol 2009;16:1412–20.
   Google Scholar
• Garcia-Albeniz X, Pericay C, Alonso-Espinaco V, Alonso V, Escudero P, Fernández-Martos C, Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab. Tumour Biol 2011;32:417–24.
   PubMed Web of Science ®Google Scholar
• Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity. World J Gastroenterol 2003;9:2843–5.
   PubMed Web of Science ®Google Scholar
• Kapsoritakis AN, Kapsoritaki AI, Davidi IP, Lotis VD, Manolakis AC, Mylonis PI, Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol 2008;8:55.
   PubMed Web of Science ®Google Scholar
• Wang YD, Tan XY, Zhang K. Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis. Mediators Inflamm 2009;2009:275072.
   PubMedGoogle Scholar
• Sadowski T, Steinmeyer J. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage 2001;9F:407–15.
   Google Scholar
• Derer S, Waetzig GH, Seegert D, Nikolaus S, Schreiber S, Rosenstiel P. A possible link between TIMP-1 induction and response to infliximab. Gut 2009;58:888.
   Google Scholar
• Arihiro S, Ohtani H, Hiwatashi N, Torii A, Sorsa T, Nagura H. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Histopathology 2001;39:50–9.
   PubMed Web of Science ®Google Scholar
• Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504–9.
   PubMed Web of Science ®Google Scholar
• Gao Q, Meijer MJ, Kubben FJ, Sier CF, Kruidenier L, van Duijn W, Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig Liver Dis 2005;37:584–92.
   PubMedGoogle Scholar
• Kofla-Dlubacz A, Matusiewicz M, Iwanczak B. Evaluation of metalloproteinase 3 and 9 concentration in serum of children with ulcerative colitis. J Crohn's Colitis Suppl 2009;3:14.
   Google Scholar
• Gao Q, Meijer MJ, Schlüter UG, van Hogezand RA, van der Zon JM, van den Berg M, Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. Inflamm Bowel Dis 2007;13:693–702.
   PubMed Web of Science ®Google Scholar
• McCarthy DA, Rampton DS, Liu YC. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991;86:489–93.
   PubMed Web of Science ®Google Scholar
• Meijer MJ, Mieremet-Ooms MA, van der Zon AM, van Duijn W, van Hogezand RA, Sier CF, Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig Liver Dis 2007;39:733–9.
   PubMedGoogle Scholar
• Becker K, Niederau C, Frieling T. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease. Z Gastroenterol 1999;37:597–605.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003;201:17–27.
   PubMed Web of Science ®Google Scholar
• Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306–21.
   PubMed Web of Science ®Google Scholar
• Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008;14:5584–9.
   PubMed Web of Science ®Google Scholar
• Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjö H, Carlson M. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Invest 2007;67:810–20.
   PubMed Web of Science ®Google Scholar
• Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol 1999;94:1304–12.
   Google Scholar
• Morohoshi Y, Matsuoka K, Chinen H, Kamada N, Sato T, Hisamatsu T, Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J Gastroenterol 2006;41:318–24.
   PubMedGoogle Scholar
• Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Clin Invest 2002;109:661–70.
   Google Scholar
• Adeyemi EO, Chadwick VS, Hodgson HJ. The effect of some anti-inflammatory agents on elastase release from neutrophils in-vitro. J Pharm Pharmacol 1990;42:487–90.
   Google Scholar
• Lehtinen P, Ashorn M, Iltanen S, Jauhola R, Jauhonen P, Kolho KL, Auvinen A. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis 2011;17:1778–83.
   PubMed Web of Science ®Google Scholar